These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36282174)

  • 21. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action.
    Dalal V; Carmicheal J; Dhaliwal A; Jain M; Kaur S; Batra SK
    Cancer Lett; 2020 Jan; 469():228-237. PubMed ID: 31629933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 23. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.
    Huang RH; Hong YK; Du H; Ke WQ; Lin BB; Li YL
    J Transl Med; 2023 Jan; 21(1):20. PubMed ID: 36635710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.
    Liu Z; Lin G; Yan Z; Li L; Wu X; Shi J; He J; Zhao L; Liang H; Wang W
    Front Immunol; 2022; 13():989275. PubMed ID: 36238300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts.
    Li R; Zhu J; Zhong WD; Jia Z
    Cancer Res; 2022 May; 82(9):1832-1843. PubMed ID: 35358302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies.
    Ji D; Yang Y; Zhou F; Li C
    Front Genet; 2022; 13():909175. PubMed ID: 36226177
    [No Abstract]   [Full Text] [Related]  

  • 28. Machine learning integrations for development of a T-cell-tolerance derived signature to improve the clinical outcomes and precision treatment of hepatocellular carcinoma.
    Li J; Chen J; Tao Q; Zheng J; Zhou Z
    Am J Cancer Res; 2023; 13(1):66-85. PubMed ID: 36777501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer.
    Li M; Li H; Chen Q; Wu W; Chen X; Ran L; Si G; Tan X
    DNA Cell Biol; 2020 Jul; 39(7):1282-1289. PubMed ID: 32522048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier.
    Lu Z; Chen H; Jiao X; Zhou W; Han W; Li S; Liu C; Gong J; Li J; Zhang X; Wang X; Peng Z; Qi C; Wang Z; Li Y; Li J; Li Y; Brock M; Zhang H; Shen L
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32792359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning.
    Yokoyama S; Hamada T; Higashi M; Matsuo K; Maemura K; Kurahara H; Horinouchi M; Hiraki T; Sugimoto T; Akahane T; Yonezawa S; Kornmann M; Batra SK; Hollingsworth MA; Tanimoto A
    Clin Cancer Res; 2020 May; 26(10):2411-2421. PubMed ID: 31992588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling.
    Mosquera Orgueira A; Díaz Arias JÁ; Cid López M; Peleteiro Raíndo A; Antelo Rodríguez B; Aliste Santos C; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; González Pérez MS; Pérez Encinas MM; Fraga Rodríguez MF; Bello López JL
    BMC Cancer; 2020 Oct; 20(1):1017. PubMed ID: 33087075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    Li MX; Sun XM; Cheng WG; Ruan HJ; Liu K; Chen P; Xu HJ; Gao SG; Feng XS; Qi YJ
    BMC Cancer; 2021 Aug; 21(1):906. PubMed ID: 34372798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-omics landscape and clinical significance of a
    Wang L; Liu Z; Zhu R; Liang R; Wang W; Li J; Zhang Y; Guo C; Han X; Sun Y
    Comput Struct Biotechnol J; 2022; 20():1154-1167. PubMed ID: 35317237
    [No Abstract]   [Full Text] [Related]  

  • 38. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
    Mo F; Lin D; Takhar M; Ramnarine VR; Dong X; Bell RH; Volik SV; Wang K; Xue H; Wang Y; Haegert A; Anderson S; Brahmbhatt S; Erho N; Wang X; Gout PW; Morris J; Karnes RJ; Den RB; Klein EA; Schaeffer EM; Ross A; Ren S; Sahinalp SC; Li Y; Xu X; Wang J; Wang J; Gleave ME; Davicioni E; Sun Y; Wang Y; Collins CC
    Eur Urol; 2018 Apr; 73(4):524-532. PubMed ID: 28330676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.
    Zou W; Li L; Wang Z; Jiang N; Wang F; Hu M; Liu R
    Bioengineered; 2021 Dec; 12(1):9006-9020. PubMed ID: 34654352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.